Anti-Leukemic Properties of Aplysinopsin Derivative EE-84 Alone and Combined to BH3 Mimetic A-1210477

Aplysinopsins are a class of marine indole alkaloids that exhibit a wide range of biological activities. Although both the indole and N-benzyl moieties of aplysinopsins are known to possess antiproliferative activity against cancer cells, their mechanism of action remains unclear. Through in vitro a...

Full description

Bibliographic Details
Main Authors: Sungmi Song, Sua Kim, Eslam R. El-Sawy, Claudia Cerella, Barbora Orlikova-Boyer, Gilbert Kirsch, Christo Christov, Mario Dicato, Marc Diederich
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/19/6/285
_version_ 1827691913708306432
author Sungmi Song
Sua Kim
Eslam R. El-Sawy
Claudia Cerella
Barbora Orlikova-Boyer
Gilbert Kirsch
Christo Christov
Mario Dicato
Marc Diederich
author_facet Sungmi Song
Sua Kim
Eslam R. El-Sawy
Claudia Cerella
Barbora Orlikova-Boyer
Gilbert Kirsch
Christo Christov
Mario Dicato
Marc Diederich
author_sort Sungmi Song
collection DOAJ
description Aplysinopsins are a class of marine indole alkaloids that exhibit a wide range of biological activities. Although both the indole and N-benzyl moieties of aplysinopsins are known to possess antiproliferative activity against cancer cells, their mechanism of action remains unclear. Through in vitro and in vivo proliferation and viability screening of newly synthesized aplysinopsin analogs on myelogenous leukemia cell lines and zebrafish toxicity tests, as well as analysis of differential toxicity in noncancerous RPMI 1788 cells and PBMCs, we identified EE-84 as a promising novel drug candidate against chronic myeloid leukemia. This indole derivative demonstrated drug-likeness in agreement with Lipinski’s rule of five. Furthermore, EE-84 induced a senescent-like phenotype in K562 cells in line with its cytostatic effect. EE-84-treated K562 cells underwent morphological changes in line with mitochondrial dysfunction concomitant with autophagy and ER stress induction. Finally, we demonstrated the synergistic cytotoxic effect of EE-84 with a BH3 mimetic, the Mcl-1 inhibitor A-1210477, against imatinib-sensitive and resistant K562 cells, highlighting the inhibition of antiapoptotic Bcl-2 proteins as a promising novel senolytic approach against chronic myeloid leukemia.
first_indexed 2024-03-10T11:12:09Z
format Article
id doaj.art-57817b0540814cc78e3934b3af71d55f
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-03-10T11:12:09Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-57817b0540814cc78e3934b3af71d55f2023-11-21T20:43:24ZengMDPI AGMarine Drugs1660-33972021-05-0119628510.3390/md19060285Anti-Leukemic Properties of Aplysinopsin Derivative EE-84 Alone and Combined to BH3 Mimetic A-1210477Sungmi Song0Sua Kim1Eslam R. El-Sawy2Claudia Cerella3Barbora Orlikova-Boyer4Gilbert Kirsch5Christo Christov6Mario Dicato7Marc Diederich8Department of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08626, KoreaDepartment of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08626, KoreaChemistry Department of Natural Compounds, National Research Centre, Dokki, 12622 Giza, EgyptDepartment of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08626, KoreaDepartment of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08626, KoreaUMR CNRS 7565 SRSMC, Université du Lorraine, 57070 Metz, FranceService d’Histologie, Faculté de Médicine, Université de Lorraine, INSERM U1256 NGERE, 54000 Nancy, FranceLaboratoire de Biologie Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg, 9, Rue Edward Steichen, 2540 Luxembourg, LuxembourgDepartment of Pharmacy, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08626, KoreaAplysinopsins are a class of marine indole alkaloids that exhibit a wide range of biological activities. Although both the indole and N-benzyl moieties of aplysinopsins are known to possess antiproliferative activity against cancer cells, their mechanism of action remains unclear. Through in vitro and in vivo proliferation and viability screening of newly synthesized aplysinopsin analogs on myelogenous leukemia cell lines and zebrafish toxicity tests, as well as analysis of differential toxicity in noncancerous RPMI 1788 cells and PBMCs, we identified EE-84 as a promising novel drug candidate against chronic myeloid leukemia. This indole derivative demonstrated drug-likeness in agreement with Lipinski’s rule of five. Furthermore, EE-84 induced a senescent-like phenotype in K562 cells in line with its cytostatic effect. EE-84-treated K562 cells underwent morphological changes in line with mitochondrial dysfunction concomitant with autophagy and ER stress induction. Finally, we demonstrated the synergistic cytotoxic effect of EE-84 with a BH3 mimetic, the Mcl-1 inhibitor A-1210477, against imatinib-sensitive and resistant K562 cells, highlighting the inhibition of antiapoptotic Bcl-2 proteins as a promising novel senolytic approach against chronic myeloid leukemia.https://www.mdpi.com/1660-3397/19/6/285aplysinopsin analogsindole alkaloidsmarine sourcechronic myeloid leukemiaBH3 mimetics
spellingShingle Sungmi Song
Sua Kim
Eslam R. El-Sawy
Claudia Cerella
Barbora Orlikova-Boyer
Gilbert Kirsch
Christo Christov
Mario Dicato
Marc Diederich
Anti-Leukemic Properties of Aplysinopsin Derivative EE-84 Alone and Combined to BH3 Mimetic A-1210477
Marine Drugs
aplysinopsin analogs
indole alkaloids
marine source
chronic myeloid leukemia
BH3 mimetics
title Anti-Leukemic Properties of Aplysinopsin Derivative EE-84 Alone and Combined to BH3 Mimetic A-1210477
title_full Anti-Leukemic Properties of Aplysinopsin Derivative EE-84 Alone and Combined to BH3 Mimetic A-1210477
title_fullStr Anti-Leukemic Properties of Aplysinopsin Derivative EE-84 Alone and Combined to BH3 Mimetic A-1210477
title_full_unstemmed Anti-Leukemic Properties of Aplysinopsin Derivative EE-84 Alone and Combined to BH3 Mimetic A-1210477
title_short Anti-Leukemic Properties of Aplysinopsin Derivative EE-84 Alone and Combined to BH3 Mimetic A-1210477
title_sort anti leukemic properties of aplysinopsin derivative ee 84 alone and combined to bh3 mimetic a 1210477
topic aplysinopsin analogs
indole alkaloids
marine source
chronic myeloid leukemia
BH3 mimetics
url https://www.mdpi.com/1660-3397/19/6/285
work_keys_str_mv AT sungmisong antileukemicpropertiesofaplysinopsinderivativeee84aloneandcombinedtobh3mimetica1210477
AT suakim antileukemicpropertiesofaplysinopsinderivativeee84aloneandcombinedtobh3mimetica1210477
AT eslamrelsawy antileukemicpropertiesofaplysinopsinderivativeee84aloneandcombinedtobh3mimetica1210477
AT claudiacerella antileukemicpropertiesofaplysinopsinderivativeee84aloneandcombinedtobh3mimetica1210477
AT barboraorlikovaboyer antileukemicpropertiesofaplysinopsinderivativeee84aloneandcombinedtobh3mimetica1210477
AT gilbertkirsch antileukemicpropertiesofaplysinopsinderivativeee84aloneandcombinedtobh3mimetica1210477
AT christochristov antileukemicpropertiesofaplysinopsinderivativeee84aloneandcombinedtobh3mimetica1210477
AT mariodicato antileukemicpropertiesofaplysinopsinderivativeee84aloneandcombinedtobh3mimetica1210477
AT marcdiederich antileukemicpropertiesofaplysinopsinderivativeee84aloneandcombinedtobh3mimetica1210477